0001214659-24-011220.txt : 20240621 0001214659-24-011220.hdr.sgml : 20240621 20240621135117 ACCESSION NUMBER: 0001214659-24-011220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240620 FILED AS OF DATE: 20240621 DATE AS OF CHANGE: 20240621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taglietti Marco CENTRAL INDEX KEY: 0001408870 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38599 FILM NUMBER: 241059533 MAIL ADDRESS: STREET 1: C/O FOREST LABORATORIES, INC. STREET 2: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc. CENTRAL INDEX KEY: 0001398733 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 208623253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-941-1900 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: MonoSol Rx, Inc. DATE OF NAME CHANGE: 20070507 4 1 marketforms-66327.xml PRIMARY DOCUMENT X0508 4 2024-06-20 0001398733 Aquestive Therapeutics, Inc. AQST 0001408870 Taglietti Marco C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059 true false false false 0 Stock Option (Right to Purchase) 2.50 2024-06-20 4 A false 38000 0 A 2025-06-20 2034-06-20 Common Stock 38000 38000 D The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date. /s/ Lori Braender, as Attorney-In-Fact 2024-06-24